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Abstract
Translation initiation of picornavirus RNA is driven by an internal ribosome entry site (IRES) element located upstream of the
initiator codon. RNA structure organization as well as RNA-protein interaction plays a fundamental role in internal initiation.
IRES activity has been mainly analyzed in the context of reporter genes, lacking regions of the viral genome potentially
affecting translation efficiency. With the aim to understand the vulnerability of the IRES and translation start region to small
molecules in the context of the viral genome, we designed a set of customized RNase-resistant 29O-methyl antisense
oligoribonucleotides (29OMe AONs) based on RNA structure data. These AONs were then used to monitor their capacity to
interfere viral RNA translation, and thus, to inhibit virus yield. Foot-and-mouth disease virus (FMDV) RNA translation can be
initiated at two in-frame AUG codons. We show here that a 29OMe AON complementary to AUG2 inhibited viral
multiplication more efficiently than the one that targeted AUG1. Furthermore, the response of the viral RNA to AONs
targeting the IRES region denoted important differences between tissue culture cells and cell-free systems, reinforcing the
need to analyze viral RNA response in living cells. Importantly, we have identified four specific motifs within the IRES
element that are targets for viral inhibitors both in tissue culture cells and in cell-free systems. The identified targets define
accessible regions to small molecules, which disturb either the RNA structural organization or the RNA-protein interactions
needed to initiate translation in FMDV RNA.
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Introduction
Foot-and-mouth disease virus (FMDV) is the prototype of the
aphthovirus genus of the Picornaviridae family. FMDV causes
a contagious disease that affects cattle and a large number of wild
cloven-hoofed ungulates [1,2]. The viral genome consists of
a positive sense, single-stranded RNA of about 8500 nts, encoding
a single polyprotein, flanked by a heavily structured untranslated
region (UTR) at the 59end (Fig. 1A). Upon entry into the cell, the
viral open reading frame is translated into a polyprotein that is
proteolytically processed by virus-encoded proteases [3]. In
common with all picornaviruses, the FMDV genome does not
contain the cap structure (m7GpppN) typically present in cellular
mRNAs at its 59 end. Instead, a viral protein (VPg) is covalently
linked to the 59end of the viral RNA [4]. The 59UTR comprises
a long hairpin (termed S), a poly(C) tract of variable length,
a variable region folding as two to four pseudoknots, the cis-
replication element (cre), and the internal ribosome entry site
(IRES) element that mediates cap-independent translation of the
viral RNA [5,6,7]. The 39UTR consists of a region of about 90 nt
and a poly(A) tail, which stimulate IRES activity and participates
in viral RNA replication [8,9]. Replication of the viral genome
occurs in the cytoplasm of infected cells. Polyprotein synthesis can
start at two in-frame AUG codons separated by 84 nt [10]. Both
AUGs are used as start codons for viral protein synthesis, although
the second one is preferentially utilized in a variety of assays
[11,12].
Picornavirus IRESes are cis-acting elements that recruit the 40S
ribosomal subunits to the mRNA with the help of cellular trans-
acting factors [13]. The FMDV IRES is distributed in structural
domains (Fig. 1A) with the first 21 nt (domain 1) forming part of
the cre element [14]. Domain 2 includes a polypyrimidine tract
(UCUUU) that provides a polypyrimidine tract-binding protein
(PTB) binding site [15]. Domain 3 consists of 210 nts, the most
apical region of which is arranged as a cruciform structure that
plays a crucial role in RNA-RNA interaction [16,17]. The
proximal part is organized as a base-paired structure interrupted
with bulges that include several non-canonical base pairs and
a helical structure essential for IRES activity [18,19]. Domain 4,
which is organized into two hairpin-loops with A-rich internal
bulges conserved between FMDV and encephalomyocarditis virus
(EMCV) [20] is responsible for the interaction with the translation
initiation factor eIF4G [21,22], an essential step in FMDV and
EMCV IRES-dependent translation initiation. Domain 5 is
composed of a conserved hairpin-loop and a polypyrimidine-rich
tract preceding the first functional AUG codon. Specific RNA
motifs located in domains 2, 4 and 5 are responsible for the
interaction with cellular proteins such as PTB, eIF4G, eIF3 and
eIF4B, amongst other host factors controlling internal initiation
[23].
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The FMDV IRES showed significant differences in the
accessibility in vitro and in vivo to dimethyl sulfate (DMS) [24],
a reagent that is permeable to cell membranes and reacts with
unpaired bases in the RNA structure. The differences in the
accessibility of the IRES to DMS suggested that the IRES region
adopts a different conformation in the cell cytoplasm compared to
naked RNA. Similarly, results of UV-crosslinked amino-methyl
psoralen-treated cells showed a local reorganization of RNA
structure. Recent Selective 29Hydroxyl Acylation analyzed by
Primer Extension (SHAPE) structural analysis revealed a modular
organization of the IRES region [25]. Additionally, clusters of
SHAPE reactive nts indicated the presence of flexible regions,
hairpin-loops and internal bulges within the IRES domains [26].
Accessibility to the FMDV IRES was also studied through
hybridization of fluorescent-labeled IRES transcripts with com-
plementary oligodeoxynucleotides printed on microarrays. It is
worth noting that the accessible regions in the microarray were
also reactive to SHAPE probing, except for specific nts within the
apical region of domain 3, around the GNRA (where N is any
nucleotide and R is a purine) stem-loop [26].
Antisense oligonucleotides are single-stranded sequences that
form a hybrid with their complementary RNA via Watson-Crick
base pairing. The resulting hybrid can block gene expression by
various mechanisms, depending on the chemical composition of
the oligonucleotide and location of the hybrid. The strength of the
hybrid depends on factors such as thermodynamic stability, the
secondary structure of the target mRNA, and the proximity of the
hybridization site to functional motifs on the designated transcript
such as translational start site. Unmodified oligonucleotides are
unstable within cells due to rapid nuclease degradation. By
contrast, phosphorothioate [27] and 29O-methyl oligoribonucleo-
tides, carrying the 29-OH residue of the ribose molecule replaced
by a methyl group, are resistant to degradation by cellular
nucleases [28]. 29O-methyl antisense oligoribonucleotides (29OMe
AONs) form high melting temperature heteroduplexes with
targeted mRNA [29] and induce antisense effect by a non-RNase
H-dependent mechanism [30,31]. Earlier studies have been
conducted to investigate the use of antisense transcripts to inhibit
FMDV viral gene expression directed against the functional AUGs
[32] and to both, the 59 and 39UTR [33,34]. An independent
study using antisense morpholino oligomers targeting the viral
RNA start codons also showed the capacity of these small
molecules to inhibit viral FMDV multiplication [35]. The latter
study showed controversial results with a previous work [36], in
which phosphorothioate antisense oligodeoxynucleotides comple-
mentary to AUG2 inhibited virus multiplication with greater effect
than those complementary to AUG1. Despite all these studies,
a deep analysis of molecules targeting the entire IRES element to
inhibit viral RNA expression in cells and in vitro was lacking.
Here, by taking advantage of the RNA structural analysis of the
IRES-AUG region [12,16–18,23–26], we have designed a set of
customized 29OMe AONs to monitor the accessibility of FMDV
in the context of full length RNA transcribed from an infectious
cDNA clone. The results indicate that the AON targeting AUG2
inhibited FMDV viral multiplication more efficiently than that
which targeted AUG1 in susceptible cells. By contrast, the results
obtained using cell-free systems indicated that AUG1 was the best
target to inhibit translation. Remarkably, four AONs (183, 207,
432 and 452) complementary to conserved motifs within the apical
region of domain 3 and domain 5, that play key roles in internal
initiation [17,37,38], were potent inhibitors in both systems,
revealing accessible IRES regions which are candidate targets for
small molecules interfering viral infectivity. Furthermore, the
accessibility of different regions of the IRES to 29OMe AONs
exhibited important differences when comparing the results
obtained in RNA-transfected cells or in vitro translation of the
same RNA. These differences, which are likely due to the
composition of the cell cytoplasm and the cell-free system,
emphasize the need to use living cells to measure the inhibitory
capacity of small molecules.
Results
Differential inhibition of FMDV RNA infectivity by 29O-
methyl-antisense oligonucleotides targeting AUG1 and
AUG2 in tissue culture cells
FMDV RNA translation initiation is peculiar in that protein
synthesis can be initiated at two start codons, AUG1 and AUG2
(Fig. 1A). While both AUGs are fully conserved in field isolates,
Figure 1. Differential effect of 29OMe AONs targeting the
initiator codons on virus yield. (A). Schematic representation the
foot-and-mouth viral genome; the position of the IRES and the initiator
codons, AUG1 and AUG2 is depicted. (B). Changes in viral yield induced
by AONs targeting AUG1 and AUG2 initiation codons. In vitro
synthetized FMDV RNA (50 pg) was annealed with the indicated
concentrations of AONs AUG1, AUG2 or the scramble SCR, prior to
transfect confluent BHK-21 cell monolayers in duplicate. Virus yield was
determined using fresh cells monolayers as the number of plaque
forming units (PFU)/ml in the supernatant 24 hpt as described in
Material and Methods, made relative to the control RNA which was set
at 100%. Values represent the mean and standard deviation of triplicate
assays (*** P,0.01). Representative examples of viral plaques stained
with crystal violet are shown. (C). Western blot of viral protein VP1
accumulated in transfected BHK-21cells 24 hpt; anti-tubulin was used
as loading control.
doi:10.1371/journal.pone.0041382.g001
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AUG2 is used more efficiently than AUG1 in infected cells
[11,39]. Earlier works have addressed the study of AUG codon
usage driven by the FMDV IRES using reporter genes
[11,12,40,41]. However, little information was available concern-
ing the influence of the complete viral RNA sequence on the
accessibility of the translation start region to small molecules.
To fill this gap, we made use of an infectious cDNA clone [42]
to study the capacity of 29OMe AONs to inhibit FMDV RNA
translation in BHK-21 cells. To ascertain the optimum inhibitory
conditions, a concentration range (1–20 nM) of three oligonucleo-
tides, AUG1, AUG2 and SCR (harboring a scrambled sequence,
Table 1) were annealed to FMDV RNA for 20 min at 37uC prior
to transfection of BHK-21 cells. Virus yield was determined 24 hpt
relative to a parallel assay conducted without AONs (Fig. S1).
Inhibition of FMDV titer was dose-dependent and sequence-
specific, being 10 or 20 nM equally efficient in inhibiting the viral
titer. Thus, 10 nM was used in all subsequent assays. Furthermore,
no effect on the transfection efficiency of the FMDV RNA was
observed in the presence of increasing amounts of SCR AON
relative to the FMDV RNA alone (Fig. S1); in addition no toxicity
was observed when cells were incubated with any of these AONs
during 48 hr by cell staining.
FMDV multiplication was inhibited in the presence of both,
AUG1 and AUG2 AONs (Fig. 1B). Differences in FMDV yield
inhibition induced by AONs were analyzed by a paired two-sided
Student t-test; differences were considered significant when
P,0.05. Overall, in agreement with the P values obtained in the
t-test, 60% was the threshold separating inhibitor from non-
inhibitor molecules. The oligonucleotide SCR had no effect on
FMDV RNA infectivity (Fig. 1B), demonstrating that the impact
of AUG1 and AUG2 AONs on viral gene expression was sequence
specific. Moreover, the decrease of virus yield induced by AUG2
(22% relative to the control assay) was 3-fold higher than that of
AUG1 (60% of the control RNA), indicating that the best target
for inhibition of viral replication is by blocking the AUG2 region.
To confirm the inhibition of viral protein synthesis by AUG1
and AUG2 AONs, a western blot against the VP1 structural
protein present in cytoplasmic extracts of BHK-21 transfected cells
prepared prior to cell detachment was performed (Fig. 1C). In
comparison to cells transfected with FMDV RNA incubated with
the SCR AON, or the control without any AON, the intensity of
VP1 confirmed that there was a strong inhibition of intracellular
viral protein synthesized and accumulated 24 hpt in the presence
of AUG2.
Response of FMDV RNA to 29OMe AONs targeting the
initiator codons using in vitro translation systems
Cell-free systems are often used to determine translation
efficiency. Thus, to measure the ability of 29OMe AONs to
inhibit protein synthesis in the context of the complete viral RNA,
FMDV RNA preincubated with SCR, AUG1 or AUG2
oligonucleotides under the same annealing conditions used in
the RNA transfection assays was used to program rabbit
reticulocyte lysates (RRL) translation. The control RNA, without
any AON, was efficiently translated, as expected. Analysis of the
translation efficiency of FMDV RNA annealed to AONs AUG1 or
AUG2 revealed a marked difference in protein synthesis (Fig. 2A).
In contrast to the data observed in transfected cells, translation
efficiency in the presence of AUG1 (15%) was significantly lower
than that observed in the presence of AUG2 (Fig. 2B). Translation
of viral proteins in the presence of AUG2 (75% of the value
observed with the control RNA alone) was non-inhibitory
(P,0.01). No inhibition was observed in the presence of SCR,
again showing a sequence-specific effect of AONs. Thus, we
conclude that there is a contrast between cell-free systems and
transfected cells in the response to AON interference depending
upon the targeted initiation codon.
Impact of 29OMe AONs targeting the IRES region on the
FMDV RNA infectivity
The differential response of the functional start codons in the
two systems used to analyze FMDV RNA translation prompted us
to assess the impact of a panel of customized 29OMe AONs
(Table 1) targeted to the entire IRES region (Fig. 3). AONs design
was carried out taking into account the structural analysis of the
IRES region [16–18,25–26]. The capacity of each oligonucleotide
to inhibit viral yield, measured by plaque forming units (PFU), was
determined 24 hpt. A significant inhibition was noted in the
59region of the IRES, where virus yield fell to 20% in the presence
of the AON 40 (Fig. 4A). On the contrary, AONs 55, 66 and 83
were non-inhibitory. These results were confirmed by the
reduction of VP1 intensity in a western blot assay using
cytoplasmic cell extracts (Fig. 4B). The specific inhibition of
AON 40 may be attributed to the pairing of the AONs to the
IRES sequence adjacent to cre (Fig. 1A), an element necessary for
viral replication [14].
The inhibitory capacity of AONs complementary to domain 3 is
shown in Fig. 5. Gross differences were observed with molecules
targeting the basal stem. While AONs 265, 282 and 300 inhibited
virus yield (36%, 39% and 52%, respectively), no inhibitory effect
was detected with AONs 104, 118, 135, and 154. The reason for
these differences is not known. Interestingly, virus yield analysis
revealed that AONs 183 and 207, complementary to the GNRA
and the RAAA stem-loops respectively (Fig. 3), reduced FMDV
RNA infectivity to about 40% (Fig. 5A). However, AONs 164 and
176, complementary to the sequences immediately upstream of the
GNRA motif, did not affect virus yield. Moreover, the 39region of
the GNRA and RAAA motifs were resistant to the effect of AONs
192 and 213. Differences in the efficiency of VP1 viral protein
synthesis 24 hpt were confirmed by western blot (Fig. 5B). The
structural organization of the FMDV IRES that depends on
interactions involving the GNRA motif and some nucleotides of
the adjacent RAAA stem-loop [16,26] may form part of the basis
of these differences.
AONs complementary to domain 4 behaved in a different way.
With the exception of AON 349 for which a severe decline in virus
yield (23% relative to the control RNA) was noticed (Fig. 6A), the
yield observed in the presence of AONs 317, 331, 360, 384, 397,
407 and 419 were all above 60%, indicating that viral
multiplication was not affected if AONs were pre-annealed to this
IRES region. Domain 5, however, did not tolerate the disruption
caused by AONs presumably due to the blocking of binding sites
of RNA-binding proteins [23,43]. Specifically, the inhibition was
slightly more pronounced in the hairpin (432, 24%) than in the
single-stranded region (452, 32%) (Fig. 6A). The inhibition of
protein synthesis by AONs complementary to domains 4 and 5
was also confirmed by a decrease in the amount of viral proteins
shown in the western blot (Fig. 6B).
The capacity of AONs to reduce viral replication was further
investigated by extending the incubation of the cells up to 48 hpt.
Compared to control RNA, the virus yields revealed that five
oligonucleotides (40, 183, 349, 432 and AUG2) remained
inhibitory 48 hpt (Fig. 7) (P,0.01). It is important to note that
these AONs showed the highest potency in inhibiting the viral
multiplication 24 hpt, with virus yields below 40%. The inhibition
noticed at 48 hpt indicated the potential of the AONs to inhibit
viral replication despite the growing number of viral RNA
molecules during the viral multiplication process.
IRES Targets Impacting Viral Gene Expression
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Interference of IRES activity in vitro denotes differences
with cultured cells
After revealing the differential impact of the AUG1 and AUG2
oligonucleotides to down-regulate IRES activity, this work sought
to further uncover the competence of AONs to intervene in the
role of the IRES within a full-length FMDV genome using an in
vitro translation system. The inhibition of polyprotein translation in
vitro induced by AONs annealed to the FMDV RNA varied
depending on each molecule (Fig. 8A, B). AONs 55 and 66,
complementary to domain 2, induced a decrease in translation
efficiency to 26% and 47%, respectively, relative to the control
RNA. However, the stem of domain 2 was able to withstand the
presence of AONs 40 and 83 (65% and 64%, respectively).
Variations were similarly observed with fifteen AONs comple-
mentary to the central IRES domain, with most of the inhibitions
noted in molecules complementary to the apical region. In terms
of IRES activity, inhibitions were prominent when conserved
motifs GNRA, RAAA and C-rich motif were disturbed (ranging
from 49 to 29%, with AONs 183, 192, 207, 213 and 247). In
contrast, AONs targeting the stem were non-inhibitory (ranging
from 64 to 118% with AONs 104 and 282, respectively). The
inhibition observed by blocking the apical region of the central
domain, reflected the susceptibility of the IRES conserved motifs
and revealed the crucial role of the central domain in the
translation process.
A striking result was noted in the lack of inhibition exerted by
AONs complementary to domain 4, with values above 60%
(Fig. 8A). However, and in agreement with the inhibition observed
in transfected cells (Fig. 6A), the AONs 432 and 452 were strong
inhibitors of protein synthesis.
Table 1. 29O-methyl Antisense Oligoribonucleotides.
Name Length Target region Sequence (59–39) GC Tm
40 15 D2: 40–26 mUmUmCmAAGUUGCAmCmGmUmU 40 47
55 16 D2: 55–40 mAmAmGmACCAGGCGGmAmGmUmU 56 57
66 16 D2: 66–51 mCmUmAmGACCUGGAAmAmGmAmC 50 46
83 15 D2: 83–68 mUmAmCmAAAGUGUUmAmCmCmC 40 47
104 19 D3: 104–85 mCmGmAmGCGUGGAGCCAAAmCmAmCmA 60 60
118 14 D3: 118–105 mAmCmUmCGCCAGUmGmGmAmU 57 59
135 18 D3: 135–118 mAmCmAmGUGCUGUUACUmAmAmCmA 39 55
154 18 D3: 154–138 mUmCmAmUGCUCCGCUACmGmAmAmG 56 58
164 14 D3: 164–150 mCmCmAmCGGCCGUmCmAmUmG 71 54
176 14 D3: 176–163 mAmAmGmGAGGAGUmUmCmCmC 57 56
183 17 D3: 183–167
17nt
mUmGmUmUACCAAGGAGmGmAmGmU 47 46
192 15 D3: 192–178 mGmUmGmGGUCCUUGmUmUmAmC 54 46
207 17 D3: 207–191 mGmUmGmGCUUUUGGCCmCmCmGmU 65 64
213 15 D3: 213–199 mGmUmGmGGCGUGGCmUmUmUmU 60 53
226 17 D3: 226–210 mAmUmGACGGGCCCGUmGmUmGmG 71 58
247 16 D3: 247–233 mUmCmGmCCGUGCUGGmGmGmUmU 69 61
265 17 D3: 265–249 mUmGmGmGUUUCGCAGUmAmAmAmG 47 56
282 18 D3: 282–265 mUmCmAmAUGUCACUUUAmAmAmGmU 27 45
300 17 D3: 300–284 mAmGmUmGUGUGGGUACmCmAmGmU 53 62
317 17 D4: 317–301 mAmUmCmCUUAGCCUGUmCmAmCmC 53 62
331 16 D4: 331–317 mGmGmGmUACCUGAAGmGmGmCmA 63 60
349 18 D4: 349–334 mAmGmUmGUCGCGUGUUAmCmCmUmC 56 61
360 18 D4: 361–344 mUmCmAmGAUCCCGAGUGmUmCmGmC 61 63
384 18 D4: 384–367 mUmUmAmUAGAAGCCCCAmGmUmCmC 50 56
397 18 D4: 397–378 mAmAmCmCGAGCGCUUUUmAmUmAmG 44 53
407 16 D4: 407–392 mGmAmAmGCUUUUUAAmAmCmCmG 38 44
419 17 D4: 419–404 mUmAmUmUCAGGCAUAGmAmAmGmC 41 49
432 17 D5: 432–415 mCmCmUmCCGGUCACCUmAmUmUmC 59 59
452 19 D5: 452–433 mUmUmGmUAAAGGAAAGGUmGmCmCmG 47 48
AUG AUG 18 luciferase AUG mCmUmUmCCAUUUUACCAmAmCmAmG 39 49
AUG1 AUG1 19 FMDV AUG1 mCmAmGmUUGUAUUCAUAGmGmGmUmC 42 52
AUG2 18 FMDV AUG2 mGmAmAmUUCCAUUUUUCmCmUmGmC 39 52
SCR 16 Random sequence mUmGmCmAGCUGACAGmUmGmUmA 50 57
2-O9methyl modifications are designated with a letter¨m¨. GC, content of GC, Tm, melting temperature.
doi:10.1371/journal.pone.0041382.t001
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Interference of virus multiplication by AONs AUG1 and
AUG2
To extend our analysis of AON inhibition to virus infection, we
used BHK-21 cell monolayers treated with AONs SCR, AUG1,
AUG2 and mock-treated to carry out a virus infection as described
in Material and Methods. Virus titer determined at time 0 was
lower than 10 PFU/ml in all samples. However, the virus titer
determined 6 hpi differed strongly between AUG1 and AUG2,
while there was no effect of the SCR relative to the control mock-
untreated cell monolayer (Fig. 9). The results indicated a significant
inhibition in the case of cells treated with AUG2 (,20% relative to
the control untreated cells, P,0.01), while the decrease in virus
titer in the presence of AUG1 was about 80% of the control cell
monolayer. These results are in full agreement with the data
obtained in infectious RNA transfections, manifesting a similar
inhibitory effect in cells transfected with FMDV RNA than in cells
infected with FMDV virus particles.
Discussion
Here we have made use of 29OMe AONs complementary to the
FMDV IRES-AUG translation start region to explore the capacity
of these molecules to interfere viral RNA translation, and thus,
viral multiplication. Specifically, we were interested in analyzing
the response of the IRES-AUG region in the context of the viral
RNA for several reasons. First, to take into account the cis-acting
elements in the viral RNA that may contribute to IRES function
that are absent in reporter sequences and second, to establish
a comparison between the responses observed in cell-free systems
and in tissue culture cells.
Our results reinforce the main role of AUG2 in viral RNA
translation in tissue culture cells. This is supported by the strong
inhibition of the virus yield measured 24 hpt with the AON
complementary to AUG2, while that complementary to AUG1
only partially reduced virus multiplication (Fig. 1B). In both cases,
the inhibition observed was dose-dependent and sequence specific
(Fig. S1). These results are consistent with a preferential use of
AUG2 in infected cells [39], as well as with the higher inhibitory
capacity of antisense oligoribonucleotides targeting AUG2 [36],
independently of using FMDV RNA-transfected cells or FMDV
infection (Fig. 9). The reasons that would explain the different
behavior of AUG1 and AUG2 AONs observed between in vitro
translation and transfected cells are unknown; however they
support a different accessibility of these two regions to external
molecules despite being only 84 nt apart. Further, our results
support the need to use in vivo assays to validate the interference of
small molecules in viral gene expression.
The interference observed with a collection of thirty-two
customized AONs targeting the entire IRES region revealed large
differences in the capacity of these molecules to inhibit viral gene
expression, and therefore multiplication of the viral RNA.
Specifically, oligonucleotides complementary to domain 2, the
apical region of domain 3, the basal region of domain 4 and
domain 5 were the most efficient inhibitors in transfected cells,
which were still detected 48 hpt (Fig. 7). This inhibition was
confirmed when the viral protein VP1 accumulated in the cell
cytoplasm prior to cell detachment was measured by immunode-
tection, indicating that the low virus yield was a consequence of
a decrease in viral RNA translation. In full agreement with these
results, phosphorothioate derivatives targeting some of these
regions were inhibitors of virus multiplication (Table S1).
Annealing of 29OMe AONs to FMDV RNA prior to program
in vitro translation indicated a differential response in some, but not
all, IRES regions. Specifically, AONs 183, 207, 432 and 452 were
inhibitory (as observed in transfected cells). However, several
AONs complementary to the apical region of domain 3 were
inhibitors in vitro but not in living cells. In agreement with this
result, differences in DMS and amino-methyl psoralen accessibility
to naked FMDV IRES or RNA expressed in the cell cytoplasm
were already noticed [24]. Since RNA structure of this particular
IRES region is constrained by tertiary interactions [16,26], it is
likely that the composition of the cell-free system differs in
cofactors influencing RNA structure. Further, the differences in
gene expression observed with the FMDV RNA when transfected
in susceptible cells or translated in vitro suggested important
conformational changes, which may depend on the interaction of
the IRES with transacting factors present in different concentra-
tions in the cell cytoplasm. In addition, interactions with other cis-
acting RNA elements such as the FMDV 39UTR [44], modifi-
cation of host factors in infected cells [45–50], or the specific
intracellular environment of viral replication [51–54] may
differentially affect expression in these systems. However, since
hamster BHK-21 or swine IBRS-2 cell lines are known to have an
inactive type I IFN system in response to FMDV infection [55,56]
it is unlikely that the differences observed between the in vitro
lysates and the transfected cells are due to type I interferon
production.
As previously mentioned, domains 4 and 5 provide the binding
site for eIFs and IRES-transacting factors (ITAFs) controlling
internal initiation of translation [38,43,57]. Disruptions caused by
the AONs targeting domain 5 were not tolerated, as reflected by
the reduced infectivity of FMDV RNA in the presence of the
AON complementary to the hairpin (432) and the single-stranded
region (452) (Figs. 6A and 7). The inhibition induced by AONs
complementary to domain 5 had similarities to those noted by
AONs 40, 183 and 349, complementary to domain 2, the apical
region of domain 3, or domain 4 (Fig. 3). Another possibility to
explain the inhibition noticed in domain 5 could be the steric block
caused by the AONs, interfering in the landing site of the
translational machinery.
Figure 2. Effect of 29OMe AONs targeting the initiator AUGs of
FMDV RNA in in vitro translation efficiency. (A). Autoradiograph
of translation products obtained from in vitro synthetized FMDV RNA
annealed, or not, with the indicated AONs and incubated with
reticulocyte lysates. Translation assays were conducted as described
in Material and Methods. The position of molecular weight markers is
indicated on the left. (B). The intensity of the lanes were determined by
densitometry and made relative to the total intensity of the lane
without any AON, which was set at 100%. Data corresponds to the
mean and standard deviation of the mean of three independent assays
(*** P,0.01; ** P,0.05). A black bar denotes inhibitory capacity relative
to the control translation reaction.
doi:10.1371/journal.pone.0041382.g002
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Our results are in partial disagreement with a previous study
that used morpholino oligomers targeting domain 5, AUG1 and
AUG2 to inhibit FMDV multiplication [35]. Furthermore, the
concentration required to inhibit viral multiplication was higher
(1–5 mM) and the interference produced by the morpholino
complementary to domain 5 was lower than that of AUG1 or
AUG2. Other IRES regions were not analyzed in the work by
Vagnozzi et al. [35]. Morpholino-modified RNAs effectively
inhibited replication of poliovirus [58], West Nile virus [59],
dengue virus [60], or severe acute respiratory syndrome
coronavirus [61], among other positive strand RNA viruses. More
recently locked nucleic acid-based (LNA) RNAs were shown to be
effective inhibitors of HCV [62]. Other RNA-based antiviral
strategies were able to suppress virus multiplication in cell culture,
as illustrated for HCV [63,64], FMDV [65] or poliovirus [58,66].
In summary, we have taken advantage of the stability of 29OMe
AONs to explore the accessibility of the entire IRES-AUG region
in the context of the viral RNA. Overall, we have identified critical
regions of the IRES element that led to a significant decrease of
virus yield when targeted with 29OMe AONs. Identification of
these regions in tissue culture cells by monitoring the reduction in
viral protein translation or reduced virus multiplication empha-
sizes the relevance of certain viral RNA region in controlling viral
gene expression. In addition, they open up new avenues to develop
novel tools aimed to inhibit viral infection.
Materials and Methods
RNA synthesis
The plasmid pMT28, encoding a cDNA copy of FMDV C-
S8c1 genome inserted into pGEM-1 under the control of the SP6
promoter was described previously [42]. Following NdeI linear-
ization FMDV RNA was transcribed in vitro using SP6 RNA
polymerase, as described [8].
29O-methyl antisense oligoribonucleotides design
Thirty-two 29O-Methyl antisense oligoribonucleotides designed
to hybridize with the IRES, AUG1 and AUG2 of FMDV RNA
(Table 1), with 29O-methyl instead of the 29OH of the ribose in
the four flanking nucleotides, were purchased from SIGMA. For
Figure 3. Secondary RNA structure of the FMDV IRES region. The modular organization of the IRES element in domains (1–2, 3, 4, and 5) is
indicated. The first 20 nt of the IRES belong to the right arm of cre (Fig. 1A); nucleotide numbering has been maintained for consistency with previous
works. The position of conserved RNA motifs refer to in the text are indicated. In-frame initiator codons AUG1 and AUG2 are separated by 84 nt
(dashed line). Blue-boxed nucleotides depict the annealing nucleotide position of the 39end of each antisense oligonucleotide. The approximate
annealing position of the customized 29O-Me AONs in the linear IRES sequence is depicted in the bottom. AON sequences are described in Table 1.
doi:10.1371/journal.pone.0041382.g003
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simplicity, 29OMe AONs are named by the IRES nt position
which is complementary to the 59 end of each oligoribonucleotide
(see Fig. 3). A scrambled sequence of 16 nt, with 50% GC content,
was included as specificity control. The scrambled sequence was
checked with NCBI-BLAST software (http://blast.ncbi.nlm.nih.
gov/) to prevent any possible match in the FMDV RNA or the
host cellular RNAs. MFold (http://www.tbi.univie.ac.at/˜ivo/
RNA/) and oligo analyzer (http://eu.idtdna.com/analyzer/
applications/oligoanalyzer/) were used to predict the secondary
structure of each antisense oligoribonucleotide to prevent self-
dimerization, formation of stable hairpins, and to optimize its
hybridization to the IRES region avoiding perfect hairpin targets
deduced from RNA probing data [16–18,25–26].
Annealing of 29OMe AONs with the RNA and in vitro
translation
The optimal inhibitory condition was determined using
a concentration range (0.1, 1, 3 and 6 mM) of two AONs, AUG
and SCR, annealed to RNA (250 ng) for 20 min at 37uC (data not
shown). In vitro translation was performed by adding the RNA
annealed with AON to a reaction mix containing 6.5 ml of
nuclease-treated rabbit reticulocyte lysates (RRL) (Promega), 1 ml
(1 mM) amino acid mix less methionine and 0.5 ml (6 mCi) 35S-
methionine in a final volume of 10 ml. Translation reaction was
carried out at 30uC for 60 min. The reaction was treated with 1 ml
of RNase A, incubated for 10 min at room temperature and
fractionated in polyacrylamide gel with sodium dodecyl sulfate
(SDS-PAGE) [11]. Inhibition of viral polypeptides synthesis was
calculated by dividing the intensity of total polypeptides translated
in the presence of the 29OMe AON to that of the control RNA
without ASO. Subsequent assays were carried out using 6 mM
29OMe AON, annealed to the target RNA at 37uC, 20 min.
RNA transfection
The infectivity of viral RNA synthesized in vitro was determined
using increasing amounts of FMDV RNA (25 pg to 2 ng) to
transfect BHK-21 cell monolayers (56105 cells); virus yield was
titrated 24 hpt in fresh cell monolayers. Typically, virus yield from
50 pg of FMDV RNA yielded about 1.66103 plaque forming
units (PFU)/ml. In the RNA infectivity assay, and prior to RNA
transfection, 50 pg of in vitro synthesized FMDV RNA was
annealed with each oligonucleotide (10 nM) for 20 min at 37uC.
Triplicates of BHK-21 cells grown in 35 mm well dishes, washed
three times with Dulbeccos modified Eagle’s medium (DMEM),
were transfected with a mixture of lipofectine-RNA annealed with
each AON in 0.5 ml of DMEM, as described [9]. Three hours
post-transfection (hpt), cell monolayers were washed with DMEM
three times, and 2 ml of fresh DMEM supplemented with 5% FCS
was added. At 24 and 48 hpt, 200 ml supernatant was collected.
Cytoplasmic cell extracts were prepared for the determination of
VP1 viral protein from transfected cells 24 hpt prior to cell
detachment, using lysis buffer (100 ml of 50 mM Tris-HCl,
pH 7.8, 120 mM NaCl, 0.5% NP40) and centrifuged at 14,000
RPM for 5 min to remove cellular debris. Transfection experi-
ments were repeated at least 3 times.
Western blot analysis
Equal amounts of total protein prepared from transfected BHK-
21 transfected cells were resolved in 10% SDS-PAGE, transferred
to a PVDF membrane (Biorad) using a semidry electrotransfer
device. VP1 protein was detected using the SD6 mouse mono-
clonal antibody (1:1000) [67] followed by goat-anti-mouse
secondary antibody coupled to horseradish peroxidase (1:2000)
(Thermo Scientific), and enhanced chemiluminescence (GE
Healthcare). After stripping using restore western blot stripping
buffer (Thermo Scientific) the same membrane was used to detect
a-tubulin as a loading control using anti-tubulin antibody (1:5000)
(Sigma).
PFU inhibition assay
Virus yield from three independent RNA infectivity assays were
titrated in fresh susceptible IBRS-2 cells to determine the capacity
of each 29OMe AON to inhibit PFU. Monolayers of IBRS-2 cells
were infected with serial dilutions of the supernatant from
transfected BHK-21 cells. One hour after adsorption, the viral
inoculum was removed and the cells were washed three times,
overlaid with DMEM medium with 0.5% agar supplemented with
2% fetal calf serum. Virus titer (PFU/ml) was scored 24 hours
post-infection (hpi) by fixing the cells with 2% formaldehyde
solution and stained with 0.3% crystal violet in 2% formaldehyde
solution. The viral titer from the 24 and 48 hpt supernatant was
determined by counting the viral plaques that developed after
24 hpi [33]. The virus yield was calculated as the mean of PFU/
Figure 4. Analysis of the effect of 29OMe AONs targeting
domain 2 of the IRES in virus yield. (A) In vitro synthetized FMDV
RNA was annealed with oligonucleotides 40, 55, 66 and 83 (see Fig. 3
and Table 1) and the scramble (SCR), prior to transfect confluent BHK-21
cell monolayers in duplicate. Virus yield was determined as PFU/ml in
the supernatant 24 hpt, and made relative to the value obtained in the
control RNA without AONs. Values represent the mean and standard
deviation of triplicate assays (*** P,0.01; ** P,0.05). Representative
examples of viral plaques stained with crystal violet are shown. (B).
Western blot of viral protein VP1 accumulated in BHK-21cells 24 hpt;
anti-tubulin was used as a loading control.
doi:10.1371/journal.pone.0041382.g004
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Figure 5. Analysis of virus yield in the presence of 29OMe AONs complementary to domain 3. (A) FMDV RNA was annealed with the
indicated AONs or a scramble (SCR), prior to transfect confluent BHK-21 cell monolayers in duplicate. Virus yield was determined as PFU/ml in the
supernatant 24 hpt, and made relative to the value obtained in the control RNA alone. Values represent the mean and standard deviation of triplicate
assays (*** P,0.01; ** P,0.05: * P,0.1). (B). Western blot of representative examples of viral protein VP1 accumulated in BHK-21cells 24 hpt; anti-
tubulin was used as a loading control.
doi:10.1371/journal.pone.0041382.g005
Figure 6. Effect of 29OMe AONs complementary to domain 5 on virus multiplication. (A) FMDV RNA was annealed with the indicated AONs
and a scramble (SCR), prior to transfect confluent BHK-21 cell monolayers in duplicate. Virus yield was determined as PFU/ml in the supernatant
24 hpt, and made relative to the value obtained in the control RNA. Values represent the mean and standard deviation of triplicate assays (***
P,0.01; ** P,0.05). (B). Western blot of representative examples of viral protein VP1 accumulated in BHK-21cells 24 hpt; anti-tubulin was used as
a loading control.
doi:10.1371/journal.pone.0041382.g006
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ml of three independent assays of FMDV RNA transfected BHK-
21 cells with each 29OMe AONs relative to the PFU/ml of FMDV
RNA transfected without oligonucleotides, which was set at 100%.
Cell monolayers were used to determine ASO cytotoxicity by cell
staining at the end of the treatment.
Challenge of AON-treated cells with FMDV virus
BHK-21 cell monolayers (16105 cells) were incubated with
SCR, AUG1 or AUG2 ASO (0.4 mM) or DMEM alone 3 h prior
to FMDV infection. Then, cell monolayers were infected with C-
S8c1 FMDV at a multiplicity of infection (MOI) of 0.1 PFU/cell.
Figure 7. Monitoring time-effect of virus yield induced by 29OMe AONs complementary to the IRES region. FMDV RNA was annealed
with the indicated AONs and a scramble (SCR), prior to transfect confluent BHK-21 cell monolayers in duplicate. Virus yield was determined as PFU/ml
in the supernatant 48 hpt, and made relative to the value obtained in the control RNA. Values represent the mean and standard deviation of triplicate
assays. A black bar denotes inhibitory capacity (*** P,0.01) relative to control transfection.
doi:10.1371/journal.pone.0041382.g007
Figure 8. Changes in FMDV RNA translation efficiency in vitro induced by 29OMe AONs. (A). Autoradiograph of translation products
obtained from FMDV RNA annealed, or not, with the indicated AONs in reticulocyte lysates. Translation assays were conducted as described in
Material and Methods. (B). The intensity of each lane was determined by densitometry and made relative to the intensity of the lane without AON,
which was set at 100%. Data correspond to the mean and standard deviation of the mean of three independent assays. A black bar denotes inhibitory
capacity relative to control RNA.
doi:10.1371/journal.pone.0041382.g008
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After 1 h of adsorption, the inoculum was removed by 3 washes
with DMEM-HCl pH 6 to inactivate free virus, twice with
DMEM to restore pH and then, incubated with DMEM
supplemented with 2% FCS and the appropriate AON (0.4 mM)
for 6 h. Supernatants were collected at 0 and 6 hpi for virus titer
determination, as described [33].
Supporting Information
Figure S1 Determination of the optimum 29OMe AON
concentration required for virus yield inhibition. In vitro
synthetized FMDV RNA (50 pg) was annealed with the indicated
concentrations of AONs AUG1, AUG2 or the scramble SCR,
prior to transfect confluent BHK-21 cell monolayers in duplicate.
Virus yield was determined using fresh cells monolayers as the
number of plaque forming units (PFU)/ml in the supernatant
24 hpt as described in Material and Methods, made relative to the
control RNA which was set at 100%. Values represent the mean
and standard deviation of triplicate assays.
(TIF)
Table S1 Inhibition of FMDV RNA infectivity by
phosphorothionate antisense oligonucleotides.
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